Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 914 | 1,125 | 960 | 178 | 973 |
| Gross Profit | 914 | 1,125 | 960 | 178 | 973 |
| Operating Expenses | 5,250 | 7,728 | 4,672 | 3,599 | 3,078 |
| Operating Income | -4,336 | -6,603 | -3,712 | -3,421 | -2,105 |
| Interest Expense | 0 | -26 | -56 | -22 | 0 |
| Other Income | 22 | 0 | 0 | 0 | 9 |
| Pre-tax Income | -4,314 | -6,577 | -3,656 | -3,399 | -2,096 |
| Income Tax | -142 | -32 | -11 | -16 | -3 |
| Net Income Continuous | -4,172 | -6,545 | -3,645 | -3,383 | -2,093 |
| Net Income | $-4,172 | $-6,545 | $-3,645 | $-3,383 | $-2,093 |
| EPS Basic Total Ops | -6.48 | -10.45 | -5.76 | -7.92 | 16.93 |
| EPS Basic Continuous Ops | -6.51 | -10.38 | -5.81 | -7.78 | -15.03 |
| EPS Diluted Total Ops | -6.48 | -10.45 | -5.76 | -7.92 | 17.29 |
| EPS Diluted Continuous Ops | -6.51 | -10.38 | -5.81 | -7.78 | 17.77 |
| EBITDA(a) | $-4,143 | $-6,406 | $-3,516 | $-3,224 | $-1,908 |